The Effect of Recombinant Human TSH on Sclerostin and Other Selected Bone Markers in Patients after Total Thyroidectomy for Differentiated Thyroid Cancer
The direct effect of TSH on bone metabolism in vivo is difficult to capture as the changes of its concentrations are followed by respective alterations of thyroid hormone levels. We evaluated the effect of recombinant human TSH (rhTSH) on sclerostin and other bone markers in 29 patients after total...
Main Authors: | Arkadiusz Zygmunt, Kinga Krawczyk-Rusiecka, Elżbieta Skowrońska-Jóźwiak, Katarzyna Wojciechowska-Durczyńska, Ewa Głowacka, Zbigniew Adamczewski, Andrzej Lewiński |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/21/4905 |
Similar Items
-
Distribution of subpopulations of dendritic cells in peripheral blood of patients treated with exogenous thyrotropin
by: Stasiołek Mariusz, et al.
Published: (2012-11-01) -
Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels
by: Skowrońska-Jóźwiak Elżbieta, et al.
Published: (2012-11-01) -
Serum sclerostin concentration reflects bone turnover and glycation in men with type 2 diabetes mellitus
by: Eisuke Tomatsu, et al.
Published: (2018-02-01) -
Detection of Polyethylene Glycol Thyrotropin (TSH) Precipitable Percentage (Macro-TSH) in Patients with a History of Thyroid Cancer
by: Massimo Giusti, et al.
Published: (2017-12-01) -
Drug discovery of sclerostin inhibitors
by: Sifan Yu, et al.
Published: (2022-05-01)